Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study
The British Journal of Psychiatry · 2025-10 · 227 (4) · 688-697
DOI: 10.1192/bjp.2024.266 ↗Kurz gefasst
Fachartikel in der Zeitschrift The British Journal of Psychiatry, online erschienen am 15.01.2025. Verfasst von Jian Rong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Scientific Research, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Global Burden of Disease, Depressive Disorder, Global Health, Disability-Adjusted Life Years. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Background
Depressive disorders pose a significant global public health challenge, yet evidence on their burden remains insufficient.
Aims
To report the global, regional and national burden of depressive disorders and their attributable risk factors from 1990 to 2021.
Methods
Data from the Global Burden of Disease 2021 were analyzed for 204 countries and territories from 1990 to 2021. We explored the age-standardised incidence, prevalence and disability-adjusted life years (DALYs) of depressive disorders by age, gender and sociodemographic index.
Results
In 2021, there were 357.44 million incident cases, 332.41 million prevalent cases and 56.33 million DALYs. Age-standardised rates for incidence, prevalence and DALYs were 4333.62, 4006.82 and 681.14 per 100 000 persons, with annual declines of 0.06%, 0.03% and 0.04%. Uganda, Greenland and Lesotho had the highest prevalence, while Spain, Mexico and Uruguay showed the largest increases. Greenland and Brunei Darussalam had the highest and lowest age-standardised DALYs rates, respectively. DALYs peaked in the 55–59 age group for men and 60–64 for women, with higher rates in women. Regionally, a U-shaped association was found between the sociodemographic index and DALYs rates. Population growth was the main driver for the increase in DALYs cases. Childhood maltreatment was the leading risk factor, with intimate partner violence affecting more females and childhood sexual abuse more males.
Conclusions
Despite decreasing trends in incidence, prevalence and DALYs rates, absolute case numbers and age-standardised rates continue to increase for depressive disorders. Tackling childhood abuse and improving depressive disorder management are crucial to reducing future burdens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Scientific Research, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Materials and Equipment, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
- Department of Scientific Research, The Second Affiliated Hospital of Anhui Medical University, Hefei, China; and Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical Univ…
ORCID-Profile: Dahai Zhao
Zitieren
APA
Rong, J., Wang, X., Cheng, P., Li, D., & Zhao, D. (2025). Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study. The British Journal of Psychiatry, 227(4), 688-697. https://doi.org/10.1192/bjp.2024.266
Vancouver
Rong J, Wang X, Cheng P, Li D, Zhao D. Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study. The British Journal of Psychiatry. 2025;227(4):688-697. doi:10.1192/bjp.2024.266
BibTeX
@article{Rong2025,
author = {Rong, Jian and Wang, Xueqin and Cheng, Pan and Li, Dan and Zhao, Dahai},
title = {Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study},
journal = {The British Journal of Psychiatry},
year = {2025},
volume = {227},
number = {4},
pages = {688--697},
doi = {10.1192/bjp.2024.266}
}
EUVIMED